Security key
G9845F208
LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF)
CUSIP: G9845F208
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Ordinary Shares, par value $0.0002 per share
- Total 13F shares
- 24,757
- Total 13F value
- $18,075
- Share change
- -298,710
- SEC-reported price per share
- $0.73
- Number of holders
- 1
- Value change
- -$304,684
- Number of sells
- 6
- Shares outstanding
- 41,218,298
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
1
Top holders
1
LSBCF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
LakeShore Biopharma Co., Ltd. SEC filings
LakeShore Biopharma Co., Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G9845F208
Recent filing periods:
Ownership snapshot
Top reported holders of LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Fung Ching Wong
Disclosed value leader
Fung Ching Wong
Comparable rows
8/8
Latest evidence
11 Jul 2025
13D/G
13F
Lead comparable stake: 24%
13D/G row: Fung Ching Wong
Showing 1-6 of 8 holder rows.
Quick read
Fung Ching Wong leads the comparable SEC ownership view at 24%.
8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Fung Ching Wong's linked filing trail.
Comparable ownership
Top 5
Fung Ching Wong
24%
FMR LLC
0.28%
HHLR ADVISORS, LTD.
0.18%
ORBIMED ADVISORS LLC
0.13%
SUPERSTRING CAPITAL MANAGEMENT LP
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Fung Ching Wong |
13D/G
|
24%
|
$9,639,290
9,836,010 shares
|
$0 | 11 Jul 2025 |
| FMR LLC |
13F
Company
|
0.28%
|
$118,838
116,508 shares
|
— | 30 Jun 2025 |
| HHLR ADVISORS, LTD. |
13F
Company
|
0.18%
|
$76,683
75,179 shares
|
— | 30 Jun 2025 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.13%
|
$55,895
54,799 shares
|
— | 30 Jun 2025 |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
Company
|
0.07%
|
$31,408
30,792 shares
|
— | 30 Jun 2025 |
| BARCLAYS PLC |
13F
Company
|
0.06%
|
$25,252
24,757 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
24,757
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q3 2025 holders
1
Holder diff
0
| Investor | Q3 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend